1-year results of the LANDMARK RCT (768 patients with severe aortic stenosis): Myval vs SAPIEN or Evolut transcatheter valves showed similar estimated freedom from death, stroke or valve-related hospitalisation (87.0% vs 86.9%), noninferior in an exploratory analysis.
Secondary analysisn = 768
Serruys et al. 1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK Trial